CAMBRIDGE, MA / ACCESS Newswire / July 30, 2025 / Moderna, Inc. (NASDAQ:MRNA) today announced that the European Commission ...

A global study on the neurological effects of the COVID-19 vaccine reveals key trends, with the U.S. leading in publications ...

Texas medical freedom advocates have been pushing against vaccine requirements and recommendations for years. Now, they're in ...

The Covid-19 pandemic turned Moderna and BioNTech into household names almost overnight. Now the two companies find ...

The COVID-19 pandemic upended life for individuals and communities worldwide. Social isolation, health mandates, illness, and economic hardships took ...

A nationwide Danish cohort study demonstrated no increased risk of serious adverse events following vaccination with JN.1-updated mRNA COVID-19 vaccines, reinforcing their safety profile and ...

Your premium access has ended, but the best of Nation.Africa is still within reach. Renew now to unlock exclusive stories and ...

The global healthcare industry stands at a crossroads. With over 4.2 billion people relying on digital health services, ...

U.S. kindergarten vaccination rates inched down again last year and the share of children with exemptions rose to an all-time ...

The global health community faces a deepening challenge—not only from infectious diseases but also from a pandemic of ...